Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
CURRENT ASSETS:
Cash and cash equivalents	$ 12,546	$ 13,116
Accounts receivable, net of allowance for doubtful accounts of $2,738 and $2,650 at 2019 and 2018, respectively	134,900	129,157
Inventories	49,311	45,664
Prepaid expenses	13,078	15,351
Income taxes receivable	8,327	13,993
Other current assets	7,071	13,696
TOTAL CURRENT ASSETS	225,233	230,977
PROPERTY, PLANT AND EQUIPMENT, net	125,699	122,917
RIGHT OF USE ASSETS	76,290
INTANGIBLES, net	17,083	13,054
GOODWILL	214,360	219,412
DEFERRED TAX ASSETS, net	66,361	11,252
OTHER ASSETS	56,492	51,215
TOTAL ASSETS	781,518	648,827
CURRENT LIABILITIES:
Accounts payable	41,995	41,155
Accrued payroll and related costs	32,108	22,549
Taxes other than payroll and income	7,118	7,488
Unearned revenues	14,070	17,325
Operating lease liabilities	12,968
Income taxes payable	1,528	2,917
Other current liabilities	15,039	11,113
TOTAL CURRENT LIABILITIES	124,826	102,547
LONG-TERM DEBT, net	290,022	289,770
LONG-TERM OPERATING LEASE LIABILITIES	62,737
DEFERRED COMPENSATION	49,162	49,359
DEFERRED TAX LIABILITIES, net	27,612	7,634
OTHER LONG-TERM LIABILITIES	34,667	38,617
COMMITMENTS AND CONTINGENCIES
EQUITY:
Preference shares, EUR 0.02 par value; 6,000,000 shares authorized, none issued or outstanding	0	0
Common shares, EUR 0.02 par value; 200,000,000 shares authorized, 44,796,252 issued and 44,354,797 outstanding at 2019 and 44,796,252 issued and 44,316,845 outstanding at 2018	1,148	1,148
Additional paid-in capital	64,064	57,438
Retained earnings	175,285	156,130
Accumulated other comprehensive income (loss)	(6,359)	(5,456)
Treasury shares (at cost), 441,455 at 2019 and 479,407 at 2018	(45,877)	(52,501)
Total Core Laboratories N.V. shareholders' equity	188,261	156,759
Non-controlling interest	4,231	4,141
TOTAL EQUITY	192,492	160,900
TOTAL LIABILITIES AND EQUITY	$ 781,518	$ 648,827